BASF, Ties

BASF Ties Catalyst Business to Modular Methanol Bet While Geismar Ramp-Up Holds the Profit Question

Published on 11/20/2026 at 20:11 | Editorial boerse-global.de
BASF and DWE partner on modular methanol plants using SYNSPIRE catalysts; analysts split as Bernstein sets EUR 59 target, Jefferies EUR 44.
BASF, Ties, Catalyst, Business, Modular, Methanol, Bet, While, Geismar, Ramp-Up Illustration mit AI erstellt.

BASF has found a partner for its methanol synthesis catalysts, but the market's verdict will hinge less on the announcement itself than on whether repeat orders follow. The Ludwigshafen-based chemicals group and DWE GmbH agreed on Wednesday to collaborate on modular plants designed to produce methanol from renewable feedstocks. DWE contributes its Power-to-Liquid technology; BASF supplies SYNSPIRE-branded catalysts for the synthesis step.

For shareholders, the key test is whether the alliance matures into a business with recurring demand rather than a one-off project. A single contract would prove little. The concept would need to be deployed across multiple plants before it carries weight in the equity story.

A $1 Billion Louisiana Bet and the Utilization Test

Attention is also fixed on Geismar, Louisiana, where BASF commissioned a new MDI production facility on November 11. The company put the investment at roughly USD 1 billion, lifting annual capacity at the integrated site to around 600,000 tonnes. Those figures describe scale and output potential — not earnings. A high utilization rate would only be a convincing signal if BASF can move the additional volumes at adequate margins.

The two strands connect: if the DWE collaboration generates several plant projects requiring catalyst supply, the upside would lie in repeatability rather than in any single order. Pair that with profitable use of the Geismar capacity, and the catalyst franchise and the completed mega-investment would reinforce each other.

Should investors sell immediately? Or is it worth buying BASF?

Two Price Targets, One Unresolved Question

Thursday's analyst notes captured how far apart valuations remain. Bernstein Research kept BASF at "Outperform" with a target of EUR 59, while Jefferies reaffirmed "Underperform" and a EUR 44 target. Whether the new projects can justify the higher view depends, on this reading, on the earnings they actually contribute.

The downside case is straightforward. Demand for modular methanol plants could lag what the collaboration makes possible, leaving BASF with scattered catalyst sales and no meaningful recurring stream. At Geismar, weak utilization would be the risk: even with rising output, earnings could fall short of expectations if the company has to make concessions on price to sell the volumes.

Portfolio Housekeeping Sets the Near-Term Calendar

BASF's decision to end its pursuit of Evonik offers a benchmark for how management weighs its own projects. The company concluded that a higher valuation was not justified given Evonik's standalone business outlook and the associated risks — a clear signal of the ceiling it was prepared to pay. Whether BASF's own ventures create more value will have to be demonstrated in operations and in sales.

Elsewhere in the portfolio, BASF signed an agreement last week to sell its global mining solutions business to SNF. The deal covers the Cork production site and roughly 140 employees, with completion expected in 2027 subject to regulatory approval and customary conditions. Closing would mark a completed step in the portfolio overhaul, though it says nothing on its own about Geismar's earning power or the sales potential of the catalysts.

Separately, BASF announced on November 10 a conversion of its European polyisobutene production: from January 2027, output destined for external customers will run exclusively on renewable electricity. The switch affects suitable products under the Oppanol B and Glissopal brands.

The bull case gains substance only if the methanol cooperation spawns further projects and Geismar converts its installed capacity into profitable sales. Should catalyst orders remain isolated, or the additional MDI output prove hard to place at acceptable margins, the optimistic scenario loses its footing. For the share price, the count of initiatives matters less than the earnings BASF ultimately extracts from them.

Ad

BASF Stock: New Analysis - 20 November

Fresh BASF information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated BASF analysis...

Disclaimer...
en | DE000BASF111 | BASF | boerse | 70541012 |